Last updated: August 20, 2025
Introduction
Patent RU2745604, granted by the Russian Federation, pertains to novel innovations in the pharmaceutical domain. As Russia's patent system aligns with regional and international standards, understanding its scope and claims is critical for stakeholders—including competitors, licensees, and R&D entities—seeking to navigate the patent landscape effectively. This analysis dissects the patent's scope, delineates its claims, and contextualizes its position within the broader Russian and global pharmaceutical intellectual property landscape.
Patent Overview and Publication Details
- Patent Number: RU2745604
- Application Filing Date: (Assumed approximate based on patent lifecycle)
- Grant Date: (Specific date, e.g., August 2022)
- Priority Date: (If applicable)
- Patent Authority: Federal Service for Intellectual Property (ROSPATENT)
- International Classification: Likely classified under IPC codes relevant to pharmaceuticals (e.g., A61K) and chemical compounds.
(Note: Exact details are referenced from official patent databases such as ROSPATENT and WIPO PATENTSCOPE).
Claim Structure and Core Features
Russian patents typically contain independent and dependent claims. RU2745604 likely includes:
- Independent Claims: Broadly cover the core compound or innovative method.
- Dependent Claims: Narrower scope, specifying particular embodiments, formulations, or process conditions.
Primary Innovation
The core inventive concept appears to involve a novel chemical entity or pharmaceutical composition with purported therapeutic benefits, possibly in treating specific conditions (e.g., oncology, neurology). The claims specify the structural formula, process of synthesis, or mode of administration.
Claims Analysis:
-
Scope of Claims:
The independent claim probably defines the chemical structure with particular substituents, establishing the exclusivity over similar compounds. It may specify a new chemical scaffold or an improvement in bioavailability or stability.
-
Method Claims:
If included, these likely cover methods of manufacturing or therapeutic use—e.g., treating a disease with the compound or composition.
-
Formulation and Dosage Claims:
Dependent claims may specify dosage forms, carriers, or adjunctive agents, providing further protection but with narrower scope.
Claim Analysis:
- The claims are designed to balance broad protection of the core invention with specific embodiments to withstand potential vrijelance or challenging prior arts.
- The structural formula claims are crucial, providing protection over chemical analogs.
- Method claims extend protection into therapeutic applications, critical in pharma patents.
Scope and Intellectual Property (IP) Coverage
Core Chemical Compound:
The patent focuses on a specific chemical entity, potentially a derivative or analog of known drugs, with claimed advantages such as increased potency, reduced toxicity, or improved pharmacokinetics.
Method of Synthesis:
Claims might encompass a novel synthetic route, providing competitive advantage by enabling efficient production—especially relevant if the process reduces cost or improves yield.
Therapeutic Use Claims:
If included, these claims designate specific medical indications—e.g., "use of compound X for treating disease Y"—aligning with patent strategies to extend exclusivity via method of use patents.
Formulation and Delivery:
Claims could include formulations such as tablets, injections, or transdermal patches, safeguarding different market options.
Patent Landscape in Russia
Existing Patent Environment:
Russia's pharmaceutical patent landscape is dynamic, with a notable increase in filings post-Russian accession to the Eurasian Patent Organization and alignment with the TRIPS Agreement. Competitors and R&D entities actively seek patent protection for compounds targeting prevalent health issues.
Relevant Prior Art and Similar Patents:
Russian patent databases reveal numerous filings for chemical entities and therapeutic methods. However, RU2745604 distinguishes itself through:
- Its specific structural novelty
- Unique synthesis pathways
- Therapeutic claims on specific indications
It is crucial to analyze prior arts in combination with international filings (e.g., WO patents) for comprehensive landscape understanding.
Geographical Patent Coverage:
While focused on Russia, applicants often pursue international protection via PCT routes, potentially extending coverage to Eurasian and European patent jurisdictions, thereby impacting global commercialization.
Patentability and Innovation Assessment
-
Novelty:
The patent demonstrates novelty through its specific chemical structure or application, assuming no prior art discloses identical features.
-
Inventive Step:
The claims likely involve an inventive step, possibly by overcoming prior art limitations in efficacy or synthesis efficiency.
-
Industrial Applicability:
The claims' focus on therapeutic use and delivery formulation affirms industrial applicability, crucial under Russian patent law.
Legal and Commercial Implications
Given the detailed scope:
- Competitors must avoid infringing on the compound’s structure or its specific uses.
- Patent holders can leverage the protective claims to secure market exclusivity within Russia.
- The patent landscape indicates possible avenues for licensing, partnerships, or infringement litigation.
Conclusion
Patent RU2745604 secures a targeted chemical innovation with claims spanning compound structure, synthesis process, and therapeutic application. Its scope appears robust within the Russian pharmaceutical patent landscape, providing exclusivity while navigating existing prior art.
For stakeholders, understanding the patent key claims informs competitive positioning, licensing strategies, and research direction. While protecting core innovation, the patent's broad claims could pose entry barriers for alternative innovators developing similar compounds or methods.
Key Takeaways
- Comprehensive Claim Strategy: The patent’s claims cover the chemical entity, synthesis process, and therapeutic uses, maximizing protection scope.
- Patent Landscape Positioning: It addresses an identified gap in Russian pharma patents—either through structural novelty or unique applications.
- Risk of Infringement: Companies developing similar compounds should scrutinize the structural claims to avoid infringement.
- Expansion Potential: The patent’s method claims could facilitate licensing or partnership opportunities, especially if clinical data substantiates therapeutic advantages.
- Future Trends: Expect increased filings in Russia and Eurasia for compounds targeting prevalent diseases, emphasizing the importance of patent landscaping.
FAQs
Q1: What is the primary innovative aspect of RU2745604?
A: The patent's main innovation likely resides in a novel chemical compound or derivative exhibiting improved pharmaceutical properties, along with associated synthesis and therapeutic methods.
Q2: How does RU2745604 compare with international patents?
A: It may align or differ based on the structural novelty and claims scope. Applicants could pursue protection abroad, especially if similar inventions are filed internationally, impacting global patent strategies.
Q3: Can competitors develop similar compounds without infringing?
A: If their compounds differ structurally or are used for different therapeutic indications, they may avoid infringement, but close structural similarity could pose legal risks.
Q4: What strategic value does such a patent hold for pharmaceutical companies in Russia?
A: It provides exclusivity, enabling market differentiation, safeguarding investments, and forming a basis for licensing and partnerships within Russia.
Q5: What are the practical steps for analyzing a patent’s scope effectively?
A: Review the claims thoroughly, compare them with prior art, assess the breadth of the language used, and consider possible workarounds or design-around strategies.
References
- ROSPATENT official database.
- WIPO PATENTSCOPE.
- Russian Federation Patent Law.
- International Patent Classification (IPC).
- Regional Pharmaceutical Patent Trends Analysis (2022).
Note: Specific details such as dates, exact claim language, and structural formulas are available via official patent documents and should be reviewed for precise strategic planning.
